Natera Inc's Fiscal Year is From January To December - All Figures are in USD, Millions.
The item "Operating-Income" stands at -289.67 Million United States Dollars for the trailing twelve months (TTM) period ending 06/30/2026, the highest value since 06/30/2025.
Natera Inc's second quarter result of -75.79 Million USD for the item "Operating Income" represents an increase of 18.95 percent compared to it's first quarter result.
Also, Natera Inc's second quarter result of -75.79 Million USD for the item "Operating Income" represents an increase of 31.33 percent compared to it's second quarter result of last year.
Looking again at the trailing twelve months series (TTM), Natera Inc's second quarter result of -289.67 Million USD for the item "Operating Income" represents an increase of 10.66 percent compared to it's first quarter result.
Regarding the One-Year-Change of the series, the current value constitutes an increase of 3.96 Million United States Dollars compared to the value the year prior.
The 1 year change is 3.96 Million United States Dollars.
The 3 year change is 221.88 Million United States Dollars.
The 5 year change is 18.39 Million United States Dollars.
The 10 year change is -219.46 Million United States Dollars.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Operating Income | 905,699,262,464.00 |
![]() | Johnson & Johnson - Operating Income | 486,508,953,600.00 |
![]() | AbbVie Inc - Operating Income | 399,570,305,024.00 |
![]() | Roche Holding AG - Operating Income | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Operating Income | 280,205,508,085.11 |